Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Iclaprim | 192314-93-5 | MFCD09837803 | 98.9% | 354.40 g/mol | C19H22N4O3 | 100 MG
SDP

Catalog No. 5000248111
Encompass_Preferred

Iclaprim is a bacterial dihydrofolate reductase inhibitor supplied as a research-grade powder for analytical and laboratory use. It demonstrates potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, with a reported MIC90 of 0.06 μg/mL. Molecular formula C19H22N4O3; molecular weight 354.40 g/mol.

  • Research-grade powder form for laboratory assays.
  • High stated purity of 98.9% for reliable analytical results.
  • Potent activity against Staphylococcus aureus (MRSA).
  • Suitable as a reference standard or tool compound in microbiology studies.
  • Available in 100 mg quantity for small-scale experiments.

Catalog No. 50-002-48111 Supplier Medchemexpress LLC Supplier No. HY101479100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Iclaprim is a bacterial dihydrofolate reductase inhibitor supplied as a research-grade powder for analytical and laboratory use. It demonstrates potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, with a reported MIC90 of 0.06 μg/mL. Molecular formula C19H22N4O3; molecular weight 354.40 g/mol.

  • Research-grade powder form for laboratory assays.
  • High stated purity of 98.9% for reliable analytical results.
  • Potent activity against Staphylococcus aureus (MRSA).
  • Suitable as a reference standard or tool compound in microbiology studies.
  • Available in 100 mg quantity for small-scale experiments.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.